glp-1 muscle gain Weight loss with medicines does not result in a disproportionate loss of mass or function in obese mice and humans Some people taking GLP-1 weight

Steiner MD, 19302014: Discoverer of proinsulin', Proceedings of the National Academy of Sciences , 12/4, 940-1

3.2 Second-generation long-acting analogs The evolution developed with the emergence of second-generation GLP-1 receptor agonists, suggesting a notable advancement in molecular design and clinical application

A study from the University of Pennsylvania and Cedars-Sinai Medical Center found a 700% increase in use of the drugs for patients without diabetes from 2019 to 2023

This coordinated activation of three complementary pathways explains the unprecedented 24.2% average weight loss observed in Phase 2 trials

Dietary tweaks such as smaller meals, cutting back on high-fat foods, and staying well hydrated can make a real difference